Pharmacokinetics and pharmacodynamics of the novel H1-receptor antagonist emedastine in healthy volunteers
暂无分享,去创建一个
B. Jansen | V. Wacheck | A. Assandri | S. Dallinger | B. Kiss | H. Schlagbauer-Wadl | U. Graselli | M. Müller
[1] N. Inagaki,et al. Characterization of antihistamines using biphasic cutaneous reaction in BALB/c mice. , 1998, Life sciences.
[2] K. Masuyama,et al. Inhibition of human eosinophil chemotaxis in vitro by the anti-allergic agent emedastine difumarate. , 1996, Immunopharmacology and immunotoxicology.
[3] S. Xu,et al. Human conjunctival epithelial cells express histamine-1 receptors coupled to phosphoinositide turnover and intracellular calcium mobilization: role in ocular allergic and inflammatory diseases. , 1996, Experimental eye research.
[4] N. Sharif,et al. Emedastine: a potent, high affinity histamine H1-receptor-selective antagonist for ocular use: receptor binding and second messenger studies. , 1994, Journal of ocular pharmacology.
[5] J. Yanni,et al. Preclinical efficacy of emedastine, a potent, selective histamine H1 antagonist for topical ocular use. , 1994, Journal of ocular pharmacology.
[6] T. Saito,et al. Inhibitory effects of emedastine difumarate on histamine release. , 1993, Japanese journal of pharmacology.
[7] K. Yokota,et al. General pharmacology of 1-(2-ethoxyethyl)-2-(4-methyl-1-homopiperazinyl)benzimidazole difumarate. 2nd communication: Effects on the circulation and the other systems. , 1988, Arzneimittel-Forschung.
[8] T. Saito,et al. General pharmacology of 1-(2-ethoxyethyl)-2-(4-methyl-1-homopiperazinyl)benzimidazole difumarate. 1st communication: effects on the central nervous system. , 1988, Arzneimittel-Forschung.
[9] T. Saito,et al. [Anti-allergic effects of 1-(2-ethoxyethyl)-2-(4-methyl-1-homopiperazinyl)benzimidazole fumarate (KB-2413)]. , 1987, Nihon yakurigaku zasshi. Folia pharmacologica Japonica.
[10] K Ito,et al. Inhibition of chemical mediator release from human leukocytes and lung in vitro by a novel antiallergic agent, KB-2413. , 1987, Immunopharmacology and immunotoxicology.
[11] C. Kamei,et al. Comparative study of various H1-blockers on neuropharmacological and behavioral effects including 1-(2-ethoxyethyl)-2-(4-methyl-1-homopiperazinyl)benzimidazole difumarate (KB-2413), a new antiallergic agent. , 1986, Archives internationales de pharmacodynamie et de therapie.
[12] Å. Lanner,et al. Reproducibility of Histamine Skin Prick Test , 1985 .